Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

OncoTherapy Science

PUBLIC STATUS
61-70 EMPLOYEES
4564 STOCK SYMBOL
$1.20 SHARE PRICE (As of Wednesday Closing)
Description

OncoTherapy Science Inc focuses on cancer-related cells and genes and develops cancer therapy products which include low molecular drugs, antibody drugs, cancer peptide vaccine, and diagnostic medicine in Japan.

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
TKS
Primary Office
  • Kanagawa
  • Japan
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore OncoTherapy Science’s full profile, request a free trial.

OncoTherapy Science Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.98 - $2.13 $175M $1.18 -$0.16 1.27M 148M

OncoTherapy Science Financials Summary

In Thousands,
USD
TTM
31-Dec-2018
FY 2018
31-Mar-2018
FY 2017
31-Mar-2017
FY 2016
31-Mar-2016
Enterprise Value 109,644 229,977 229,118 303,661
Revenue 2,317 1,906 2,646 2,229
EBITDA (26,161) (25,004) (26,854) (22,296)
Net Income (23,531) (25,720) (27,707) (23,286)
Total Assets 52,297 75,483 94,742 121,564
Public Fundamental Data provided by Morningstar, Inc. disclaimer